BG
ALKS icon

Bellevue Group’s Alkermes ALKS Stock Holding History

Bellevue Group’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.3M Buy
120,243
+111,373
+1,256% +$4.35M 0.13% 80
2026
Q1 		$314K Buy
8,870
+2,276
+35% +$70.6K 0.01% 122
2025
Q4 		$185K Hold
6,594
– – ﹤0.01% 153
2025
Q3 		$198K Buy
+6,594
New +$186K ﹤0.01% 133
2024
Q3 		– Sell
-18,000
Closed -$434K – 165
2024
Q2 		$434K Sell
18,000
-6,144
-25% -$151K 0.01% 131
2024
Q1 		$654K Sell
24,144
-27,968
-54% -$794K 0.01% 125
2023
Q4 		$1.45M Sell
52,112
-29,588
-36% -$769K 0.02% 115
2023
Q3 		$2.29M Hold
81,700
– – 0.04% 111
2023
Q2 		$2.56M Buy
81,700
+17,500
+27% +$530K 0.04% 109
2023
Q1 		$1.81M Buy
64,200
+28,700
+81% +$782K 0.03% 118
2022
Q4 		$1.58M Buy
+35,500
New +$849K 0.02% 128
2022
Q3 		– Sell
-107,200
Closed -$3.19M – 177
2022
Q2 		$3.19M Buy
107,200
+32,200
+43% +$925K 0.05% 118
2022
Q1 		$1.97M Buy
+75,000
New +$1.86M 0.02% 135
2020
Q1 		– Sell
-168,400
Closed -$3.44M – 216
2019
Q4 		$3.44M Buy
+168,400
New +$3.35M 0.05% 118
2018
Q3 		– Sell
-32,650
Closed -$1.34M – 139
2018
Q2 		$1.34M Sell
32,650
-18,250
-36% -$831K 0.11% 108
2018
Q1 		$2.95M Sell
50,900
-800
-2% -$46.8K 0.29% 63
2017
Q4 		$2.83M Sell
51,700
-4,400
-8% -$225K 0.3% 69
2017
Q3 		$2.85M Sell
56,100
-81,500
-59% -$4.36M 0.3% 71
2017
Q2 		$7.98M Buy
137,600
+98,100
+248% +$5.7M 0.94% 43
2017
Q1 		$2.31M Sell
39,500
-3,000
-7% -$170K 0.31% 74
2016
Q4 		$2.36M Sell
42,500
-9,000
-17% -$481K 0.48% 54
2016
Q3 		$2.42M Sell
51,500
-14,000
-21% -$666K 0.44% 64
2016
Q2 		$2.83M Hold
65,500
– – 0.53% 56
2016
Q1 		$2.24M Buy
+65,500
New +$2.59M 0.41% 74

Other funds holding ALKS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Bellevue Group's ALKS Position: Q2 2026 in Review

Bellevue Group increased its Alkermes (ALKS) stake by 1,256% in Q2 2026, buying an estimated $4.35M and bringing the position to 120,243 shares worth $6.3M. The position accounts for 0.13% of the portfolio, ranked #80.

Bellevue Group first reported a position in ALKS in Q1 2016 and has held it in 24 quarters since. The position peaked at $7.98M in Q2 2017. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Bellevue Group held 120,243 shares of Alkermes worth $6.3M as of Q2 2026.
  • Bellevue Group bought 111,373 Alkermes shares in Q2 2026, an estimated $4.35M.
  • Alkermes made up 0.13% of Bellevue Group's portfolio in Q2 2026, its #80 holding.
  • Bellevue Group first reported a position in Alkermes in Q1 2016 and has held it in 24 quarters since.
  • Bellevue Group's Alkermes position peaked at $7.98M in Q2 2017.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Bellevue Group's 13F filing for Q2 2026, filed 14 Aug 2026.